Canada authorizes Moderna Ebola vaccine trials
Canada has approved the start of clinical trials for a new Moderna vaccine aimed at the "BondiBogu" strain of the Ebola virus, with the goal of assessing the vaccine's safety, side effects, and determining safe dosages. So far, there have been no reported cases of Ebola in Canada, but efforts continue to develop vaccines through multiple stages, especially as the new strain's spread has intensified in the Democratic Republic of Congo, leading to over 1,700 deaths since May. The initiatives include trials of vaccines based on mRNA technology, those using live attenuated virus technology, as well as the development of medical treatments according to the World Health Organization.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading